RU2014146037A - METHOD FOR SELECTING BLOOD DONORS FOR PLASMA FOR THE TREATMENT OF PATIENTS WITH INFECTIOUS DISEASES AND COMPLICATIONS AFTER OPERATIVE INTERVENTIONS, INJURIES AND BURNS - Google Patents

METHOD FOR SELECTING BLOOD DONORS FOR PLASMA FOR THE TREATMENT OF PATIENTS WITH INFECTIOUS DISEASES AND COMPLICATIONS AFTER OPERATIVE INTERVENTIONS, INJURIES AND BURNS Download PDF

Info

Publication number
RU2014146037A
RU2014146037A RU2014146037A RU2014146037A RU2014146037A RU 2014146037 A RU2014146037 A RU 2014146037A RU 2014146037 A RU2014146037 A RU 2014146037A RU 2014146037 A RU2014146037 A RU 2014146037A RU 2014146037 A RU2014146037 A RU 2014146037A
Authority
RU
Russia
Prior art keywords
injuries
complications
burns
patients
treatment
Prior art date
Application number
RU2014146037A
Other languages
Russian (ru)
Other versions
RU2601372C2 (en
Inventor
Владимир Николаевич Вильянинов
Николай Васильевич Бельгесов
Сергей Петрович Калеко
Сергей Михайлович Романенко
Елена Петровна Фомина
Александр Борисович Макеев
Ирина Борисовна Тихменева
Ирина Владимировна Малкова
Original Assignee
Федеральное государственное бюджетное военное образовательное учреждение высшего профессионального образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное военное образовательное учреждение высшего профессионального образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА) filed Critical Федеральное государственное бюджетное военное образовательное учреждение высшего профессионального образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА)
Priority to RU2014146037/15A priority Critical patent/RU2601372C2/en
Publication of RU2014146037A publication Critical patent/RU2014146037A/en
Application granted granted Critical
Publication of RU2601372C2 publication Critical patent/RU2601372C2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Способ отбора доноров для получения плазмы крови с целью лечения пациентов с инфекционными заболеваниями и осложнениями после оперативных вмешательств, травм и ожогов путем исследования иммунологических показателей крови, отличающийся тем, что исследуют содержание бактерицидного белка, и забор крови осуществляют у лиц, в плазме крови которых его концентрация составляет от 3,5 нг/мл - у мужчин и 1,8 нг/мл - у женщин.A method for selecting donors for obtaining blood plasma for the treatment of patients with infectious diseases and complications after surgical interventions, injuries and burns by examining immunological parameters of blood, characterized in that the content of bactericidal protein is examined, and blood sampling is carried out in persons in whose blood plasma the concentration is from 3.5 ng / ml in men and 1.8 ng / ml in women.

Claims (1)

Способ отбора доноров для получения плазмы крови с целью лечения пациентов с инфекционными заболеваниями и осложнениями после оперативных вмешательств, травм и ожогов путем исследования иммунологических показателей крови, отличающийся тем, что исследуют содержание бактерицидного белка, и забор крови осуществляют у лиц, в плазме крови которых его концентрация составляет от 3,5 нг/мл - у мужчин и 1,8 нг/мл - у женщин. A method for selecting donors for obtaining blood plasma for the treatment of patients with infectious diseases and complications after surgical interventions, injuries and burns by examining immunological parameters of blood, characterized in that the content of bactericidal protein is examined, and blood sampling is carried out in persons in whose blood plasma the concentration is from 3.5 ng / ml in men and 1.8 ng / ml in women.
RU2014146037/15A 2014-11-17 2014-11-17 Method for selecting donors of blood plasma using for treating patients suffering from infectious diseases and postoperative, injury and burn complications RU2601372C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2014146037/15A RU2601372C2 (en) 2014-11-17 2014-11-17 Method for selecting donors of blood plasma using for treating patients suffering from infectious diseases and postoperative, injury and burn complications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2014146037/15A RU2601372C2 (en) 2014-11-17 2014-11-17 Method for selecting donors of blood plasma using for treating patients suffering from infectious diseases and postoperative, injury and burn complications

Publications (2)

Publication Number Publication Date
RU2014146037A true RU2014146037A (en) 2016-06-10
RU2601372C2 RU2601372C2 (en) 2016-11-10

Family

ID=56114802

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014146037/15A RU2601372C2 (en) 2014-11-17 2014-11-17 Method for selecting donors of blood plasma using for treating patients suffering from infectious diseases and postoperative, injury and burn complications

Country Status (1)

Country Link
RU (1) RU2601372C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2665170C2 (en) * 2016-12-08 2018-08-28 Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Method for treatment of patients with complications by nosocomial infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1192208A1 (en) * 1984-02-09 1987-04-23 Kirov Nii Gematologii Pereliva Method for selecting donors for producing antitetanic plasma
SE502351C2 (en) * 1992-06-05 1995-10-09 Ulla Meirik Procedure and apparatus for blood sampling
EP1121149A4 (en) * 1998-08-31 2002-03-20 Inhibitex Inc Staphylococcal immunotherapeutics via donor selection and donor stimulation
EP2197473A2 (en) * 2007-09-11 2010-06-23 Mondobiotech Laboratories AG Therapeutic uses of b-type natriuretic peptide and human growth hormone 1-43

Also Published As

Publication number Publication date
RU2601372C2 (en) 2016-11-10

Similar Documents

Publication Publication Date Title
MX2023000378A (en) Oxygen reduction disposable kits, devices and methods of use thereof.
MA52909A (en) METHODS FOR INCREASING RED BLOOD CELLS AND SICKLE CELL TREATMENT
BR112018069023A2 (en) cholestatic disease treatment methods
JOP20200230A1 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
DOP2016000102A (en) (AZA) PIRIDOPIRAZOLOPIRIMIDINONAS AND INDAZOLOPIRIMIDINONAS AND ITS USE
BR112017012045A2 (en) method for stopping rcp output instructions, and automatic external defibrillator
CY1124922T1 (en) NOVEL STABLE PHARMACEUTICAL FORM FOR FXIA ANTIBODIES
WO2015067755A3 (en) Novel methods and antibodies for treating coagulapathy
EA201892265A1 (en) METHODS OF TREATMENT OF OPHTHALMIC DISEASES
EP4252742A3 (en) Fluticasone furoate in the treatment of copd
EA201691656A2 (en) THERAPEUTIC WAYS WITH THE USE OF NORIBOGOGINE AND RELATED COMPOUNDS
EA201692111A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DANIRYXIN FOR TREATING INFECTIOUS DISEASES
EA201891922A1 (en) DRUG FOR THE TREATMENT OF INFECTIONS AGAINST THE DIABETIC STOP BACKGROUND
RU2014146037A (en) METHOD FOR SELECTING BLOOD DONORS FOR PLASMA FOR THE TREATMENT OF PATIENTS WITH INFECTIOUS DISEASES AND COMPLICATIONS AFTER OPERATIVE INTERVENTIONS, INJURIES AND BURNS
EA201500765A1 (en) METHODS OF TREATING CARDIOVASCULAR DISEASES
WO2018026969A3 (en) Plazomicin antibodies and methods of use
EA201990550A1 (en) OPHTHALMIC DRUG INCLUDING THE ASOLIC COMPOUND
EA201500232A1 (en) Three (hetero) arylpyrazoles and their use
EA201890014A1 (en) THERAPEUTIC COMPOSITIONS CONTAINING DIPYRIDAMOL, KITS FOR TREATMENT, CONTAINING THESE COMPOSITIONS, AND METHODS OF THEIR MANUFACTURE
EA201692564A1 (en) COMBINED THERAPY
RU2011113265A (en) METHOD FOR DIAGNOSIS OF EYE INJURIES
RU2016142983A (en) METHOD FOR SURGICAL TREATMENT OF PATIENTS WITH TOTAL Cicatricial Deformations of the Face
EA202091647A1 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ACIDOUS OR HYPOXIC TISSUE TISSUE
EA201500888A1 (en) NON-INVASIVE METHOD OF LASER NANODIAGNOSTICS OF ONCOLOGICAL DISEASES
MY170270A (en) Method to extract leech hirudin

Legal Events

Date Code Title Description
HE9A Changing address for correspondence with an applicant
MM4A The patent is invalid due to non-payment of fees

Effective date: 20161231